(HBI) Hanesbrands - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4103451021

HBI: Underwear, Socks, Bras, Shapewear, T-Shirts, Fleece, Activewear

Hanesbrands Inc. (NYSE:HBI) stands as a cornerstone in the consumer goods sector, specializing in the design, manufacturing, and distribution of innerwear and activewear. With a legacy dating back to 1901, the company has carved out a significant presence in the Americas, Europe, Asia-Pacific, and beyond. Its operations are neatly divided into three segments: Innerwear, Activewear, and International, each contributing to a diverse portfolio that meets the everyday needs of consumers.

The companys product lineup is both extensive and essential, encompassing mens underwear, womens panties, childrens underwear, and socks, alongside intimate apparel such as bras and shapewear. Their activewear range includes T-shirts, fleece, performance apparel, and teamwear, catering to both casual and athletic needs. Additionally, Hanesbrands licenses its Champion brand for footwear and sports accessories, further expanding its market reach.

With a brand portfolio that includes Hanes, Champion, Maidenform, and others, Hanesbrands commands a strong position in the market. These brands are distributed through a variety of channels, including retailers, wholesalers, and third-party embellishers, ensuring broad accessibility. This diverse brand strategy allows the company to cater to a wide demographic, from everyday essentials to premium products.

Headquartered in Winston-Salem, North Carolina, Hanesbrands operates with a global outlook, leveraging its international segment to tap into growing markets. This strategic approach underscores its commitment to meeting consumer needs worldwide, supported by a robust supply chain and brand recognition.

From a financial perspective, Hanesbrands boasts a market capitalization of approximately $2.2 billion, with a forward P/E ratio of 11.31, signaling investor confidence in future growth. The price-to-sales ratio of 0.63 may indicate a valuation consideration, while the high price-to-book ratio of 64.78 warrants attention. These metrics, coupled with the companys

Additional Sources for HBI Stock

HBI Stock Overview

Market Cap in USD 2,133m
Sector Consumer Cyclical
Industry Apparel Manufacturing
GiC Sub-Industry Apparel, Accessories & Luxury Goods
IPO / Inception 2006-09-06

HBI Stock Ratings

Growth 5y -11.0%
Fundamental -17.6%
Dividend 4.33%
Rel. Strength -9.48
Analysts 3/5
Fair Price Momentum 5.12 USD
Fair Price DCF 13.96 USD

HBI Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y -100.00%
Payout Consistency 73.3%

HBI Growth Ratios

Growth Correlation 3m -88.6%
Growth Correlation 12m 69%
Growth Correlation 5y -70.3%
CAGR 5y -1.84%
CAGR/Max DD 5y -0.02
Sharpe Ratio 12m -0.73
Alpha -1.55
Beta 1.750
Volatility 42.77%
Current Volume 6270.7k
Average Volume 20d 6231.1k
What is the price of HBI stocks?
As of April 02, 2025, the stock is trading at USD 5.73 with a total of 6,270,681 shares traded.
Over the past week, the price has changed by -3.05%, over one month by -4.02%, over three months by -28.64% and over the past year by -0.17%.
Is Hanesbrands a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Hanesbrands is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -17.60 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HBI as of April 2025 is 5.12. This means that HBI is currently overvalued and has a potential downside of -10.65%.
Is HBI a buy, sell or hold?
Hanesbrands has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold HBI.
  • Strong Buy: 1
  • Buy: 1
  • Hold: 3
  • Sell: 1
  • Strong Sell: 1
What are the forecast for HBI stock price target?
According to ValueRays Forecast Model, HBI Hanesbrands will be worth about 5.7 in April 2026. The stock is currently trading at 5.73. This means that the stock has a potential downside of -1.05%.
Issuer Forecast Upside
Wallstreet Target Price 7.8 35.4%
Analysts Target Price 8.2 42.9%
ValueRay Target Price 5.7 -1%